SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-017225
Filing Date
2022-05-03
Accepted
2022-05-03 07:20:51
Documents
57
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-10q_20220331.htm   iXBRL 10-Q 2641780
2 EX-31.1 sage-ex311_12.htm EX-31.1 9330
3 EX-31.2 sage-ex312_7.htm EX-31.2 9279
4 EX-32.1 sage-ex321_8.htm EX-32.1 8635
5 GRAPHIC g015pbwucauj000001.jpg GRAPHIC 152660
  Complete submission text file 0001564590-22-017225.txt   9209275

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20220331.xsd EX-101.SCH 50707
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20220331_cal.xml EX-101.CAL 42141
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20220331_def.xml EX-101.DEF 188100
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20220331_lab.xml EX-101.LAB 391406
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20220331_pre.xml EX-101.PRE 306714
51 EXTRACTED XBRL INSTANCE DOCUMENT sage-10q_20220331_htm.xml XML 1797121
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 22884588
SIC: 2834 Pharmaceutical Preparations